Geneart Posts 16 Percent Revenue Growth for Q3 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Geneart today reported third-quarter revenue growth of 16 percent and a sharp increase in its profit.

The German synthetic genomics firm reported revenues of €5 million ($6.9 million) for the quarter compared to €4.3 million for the third quarter of 2009.

Its earnings before interest and taxes was €135,000, up sharply from €25,000 for Q3 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."